Drugs / Chimeric Antigen Receptor T Cells (CAR-T) Targeting Igβ Targets
Chimeric Antigen Receptor T Cells (CAR-T) Targeting Igβ Targets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05312476 | May 2026 | B-cell non-Hodgkin lymphoma | The First Affiliated Hospital of Soochow University | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chimeric Antigen Receptor T Cells (CAR-T) Targeting Igβ Targets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05312476 ↗ |
| Modality | Cell therapy | “Chimeric antigen receptor T cells targeting Igβ targets (CAR-T)” NCT05312476 ↗ |